Melatonin synergized with cyclosporine a improves cardiac allograft survival by suppressing inflammation and apoptosis

Molecular Medicine Reports

Volumn 10, Issue 3, 2014, Pages 1323-1328

  Liu, Chen ^a   Hong, Tao ^a   Shao, Mengping ^a   Chen, Zhenghang ^a   Wang, Chunsheng ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Apoptosis; Cardiac allograft; Cyclosporine A; Melatonin; Proinflammatory cytokines

Indexed keywords

CYCLOSPORIN A; MELATONIN; PROTEIN BCL 2; SYNAPTOTAGMIN I; BAX PROTEIN, RAT; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 2; NUCLEOCYTOPLASMIC TRANSPORT PROTEIN; P65 ONCOFETAL MRNA TRANSPORT PROTEIN, RAT; PROTEIN BAX; TUMOR NECROSIS FACTOR ALPHA; TUMOR PROTEIN;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CARDIAC GRAFT REJECTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; GRAFT SURVIVAL; HEART GRAFT; HEART MUSCLE CELL; HISTOPATHOLOGY; INFLAMMATION; MALE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RAT; SURVIVAL RATE; SURVIVAL TIME; UPREGULATION; ALLOGRAFT; ANIMAL; BLOOD; DRUG EFFECTS; GENETICS; HEART; HEART TRANSPLANTATION; METABOLISM; MUSCLE CELL; PHYSIOLOGY; SPRAGUE DAWLEY RAT; WISTAR RAT;

ALLOGRAFTS; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CYCLOSPORINE; DRUG SYNERGISM; GRAFT SURVIVAL; HEART; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-2; MALE; MELATONIN; MUSCLE CELLS; NEOPLASM PROTEINS; NUCLEOCYTOPLASMIC TRANSPORT PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84905514199     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2382     Document Type: Article

References (24)

1. Gill JS: Cardiovascular disease in transplant recipients: current and future treatment strategies. Clin J Am Soc Nephrol 3 (Suppl 2): S29-S37, 2008.
2. Bruschi G, Colombo T, Oliva F, et al: Heart transplantation: 25 years' single-centre experience. J Cardiovasc Med (Hagerstown) 14: 637-647, 2013.
3. Fiorelli AI, Branco JN and Dinkhuysen JJ, et al: Risk factor analysis of late survival after heart transplantation according to donor profile: a multi-institutional retrospective study of 512 transplants. Transplant Proc 44: 2469-2472, 2012.
4. Suzuki J, Ogawa M, Hirata Y, Nagai R and Isobe M: Effects of immunoglobulin to prevent coronary allograft vasculopathy in heart transplantation. Expert Opin Ther Targets 16: 783-789, 2012.
5. Tedoriya T, MacDonald PS, Keogh AM, Wilson M and Spratt PM: Reversal of chronic cyclosporin nephrotoxicity after heart transplantation. J Heart Lung Transplant 20: 247-248, 2001.
6. Aumente MD, Arizón JM, Segura J, et al: Relationship between pharmacokinetic parameters of cyclosporin and the incidence of acute rejection after heart transplantation. Transplant Proc 37: 4014-4017, 2005. (Pubitemid 43015240)
7. Baan CC, Vaessen LM, Balk AH, et al: Cyclosporin A sensitivity of allo-specific precursor and committed cytotoxic T lymphocytes after clinical heart transplantation. Transplant Proc 26: 2849-2851, 1994. (Pubitemid 24329339)
8. Werkö L: Cyclosporin as a cause of hypertension in patients with heart transplantation. Lakartidningen 88: 503, 1991 (In Swedish).
9. Huang XP, Sun Z, Miyagi Y, et al: Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair. Circulation 122: 2419-2429, 2010.
10. Espino J, Pariente JA and Rodríguez AB: Oxidative stress and immunosenescence: therapeutic effects of melatonin. Oxid Med Cell Longev 2012: 670294, 2012.
11. Fildes JE, Yonan N and Keevil BG: Melatonin - a pleiotropic molecule involved in pathophysiological processes following organ transplantation. Immunology 127: 443-449, 2009.
12. Gilad E, Wong HR, Zingarelli B, et al: Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFkappaB activation. Faseb J 12: 685-693, 1998. (Pubitemid 28247147)
13. Jung FJ, Yang L, Härter L, et al: Melatonin in vivo prolongs cardiac allograft survival in rats. J Pineal Res 37: 36-41, 2004. (Pubitemid 38969018)
14. Cardell M, Jung FJ, Zhai W, et al: Acute allograft rejection and immunosuppression: influence on endogenous melatonin secretion. J Pineal Res 44: 261-266, 2008. (Pubitemid 351392939)
15. Eşrefoǧlu M1, Kuruş M and Sahna E: The beneficial effect of melatonin on chronic cyclosporin A nephrotoxicity in rats. J Int Med Res 31: 42-44, 2003.
16. Rezzani R, Buffoli B, Rodella L, Stacchiotti A and Bianchi R: Protective role of melatonin in cyclosporine A-induced oxidative stress in rat liver. Int Immunopharmacol 5: 1397-1405, 2005. (Pubitemid 40813296)
17. Yoo YM and Jeung EB: Melatonin suppresses cyclosporine A-induced autophagy in rat pituitary GH3 cells. J Pineal Res 48: 204-211, 2010.
18. Jessup M, Banner N and Brozena S, et al: Optimal pharmacologic and non-pharmacologic management of cardiac transplant candidates: approaches to be considered prior to transplant evaluation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates - 2006. J Heart Lung Transplant 25: 1003-1023, 2006. (Pubitemid 44376581)
19. Carrillo-Vico A, Lardone PJ, Naji L, et al: Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects. J Pineal Res 39: 400-408, 2005.
20. Santello FH, Frare EO, Caetano LC, AlonsoToldo MP and do Prado JC Jr: Melatonin enhances pro-inflammatory cytokine levels and protects against Chagas disease. J Pineal Res 45: 79-85, 2008. (Pubitemid 351986265)
21. Tang EH, Libby P, Vanhoutte PM and Xu A: Anti-inflammation therapy by activation of prostaglandin EP4 receptor in cardiovascular and other inflammatory diseases. J Cardiovasc Pharmacol 59: 116-123, 2012.
22. Wolters SL, Corsten MF, Reutelingsperger CP, Narula J and Hofstra L: Cardiovascular molecular imaging of apoptosis. Eur J Nucl Med Mol Imaging 34 (Suppl 1): S86-S98, 2007. (Pubitemid 46956023)
23. Szabolcs M, Michler RE and Yang X, et al: Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase. Circulation 94: 1665-1673, 1996. (Pubitemid 26320273)
24. Gedik HS, Korkmaz K, Erdem H, Karakilic E, Lafci G and Ankarali H: Protective effect of heparin in the end organ ischemia/reperfusion injury of the lungs and heart. J Cardiothorac Surg 7: 123, 2012.